Published on September 9, 2009 at 6:50 AM
Research and Markets (http://www.researchandmarkets.com/research/d4d0ab/the_top_40_nonu_s) has announced the addition of the "The Top 40 Non-U.S. Point-Of-Care Diagnostics Manufacturing Companies" report to their offering.
According to Christopher P. Price, Visiting Professor, Clinical Biochemistry, University of Oxford, 'The purpose of point of care testing is the provision of a test result at the most appropriate point in time; enabling a decision on action to be taken that will result in an improved health outcome, without incurring additional costs.'
The global IVD market has shown consistent growth of 6.72 percent annually, a trend that is expected to continue until 2012. Point-Of-Care (POC), the largest segment, is estimated to grow into an US$18 billion market by 2012.
The growth is being driven by a shift in focus away from acute care and late stage interventions to earlier and minimally invasive treatments. In the drive to reduce time spent in hospital, more tests are being carried out in a variety of settings - hospital, ambulance, doctor's office and even in the home. The growth is being facilitated by the development of innovative technologies such as lab-on-a-chip (LOAC). LOAC technology aims to bring together the different steps in a laboratory setting onto one chip. Because of the simplified process, physicians can easily perform the tests at POC, negating the necessity for sending samples to high-tech laboratories and waiting days for the results.
There are many POC Diagnostics Manufacturing Companies in the world. This report profiles the Top 40 outside the United States.
http://www.researchandmarkets.com